{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:49:40Z","timestamp":1776883780113,"version":"3.51.2"},"reference-count":83,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.3934\/microbiol.2018.2.334","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T22:59:38Z","timestamp":1526338778000},"page":"334-346","source":"Crossref","is-referenced-by-count":6,"title":["Autoimmune liver disease and the enteric microbiome"],"prefix":"10.3934","volume":"4","author":[{"given":"Kerri","family":"Glassner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"1 Lynda K and David M Underwood Center for Digestive Disorders, Division of Gastroenterology and Hepatology, Houston Methodist Hospital, Weill Cornell Medical College, 6550 Fannin Street, SM 1201, Houston, TX 77030, USA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamonn","family":"MM Quigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lissa","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"W Victor III","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"2 Sherrie and Alan Conover Center for Liver Disease, Houston Methodist Hospital, Weill Cornell Medical College, 6550 Fannin Street, SM 1201, Houston, TX 77030, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2321","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","author":"Huttenhower C, Gevers D, Knight R, et al.","journal-title":"<em>Nature<\/em>"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1159\/000328042","article-title":"Programming of host metabolism by the gut microbiota","author":"Backhed F","journal-title":"<em>Ann Nutr Metab<\/em>"},{"key":"3","article-title":"Talking microbes: when gut bacteria interact with diet and host organs","unstructured":"3.         Cani P, Everard A (2015) Talking microbes: when gut bacteria interact with diet and host organs. <em>Mol Nutr Food Res<\/em> 60: 58\u201366."},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1038\/nature12480","article-title":"Dietary intervention impact on gut microbial gene richness","author":"Cotillard A, Kennedy S, Kong L, et al.","journal-title":"<em>Nature<\/em>"},{"key":"5","article-title":"Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production","unstructured":"5.         Wu G, Compher C, Chen E, et al. (2014) Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. <em>Gut<\/em> 65: 63\u201372."},{"key":"6","article-title":"Stability of gut enterotypes in korean monozygotic twins and their association with biomarkers and diet","unstructured":"6.         Lim M, Rho M, Song Y, et al. (2014) Stability of gut enterotypes in korean monozygotic twins and their association with biomarkers and diet. <em>Sci Rep<\/em> 4: 7348."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1101\/gr.194118.115","article-title":"Genetic and environmental control of host-gut microbiota interactions","author":"Org E, Parks B, Joo J, et al.","journal-title":"<em>Genome Res<\/em>"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","author":"Tilg H, Cani P, Mayer E, et al.","journal-title":"<em>Gut<\/em>"},{"key":"9","article-title":"The enteric microbiome in hepatobiliary health and disease","unstructured":"9.         Tabibian J, Varghese C, LaRusso N, et al. (2015) The enteric microbiome in hepatobiliary health and disease. <em>Liver Int<\/em> 36: 480\u2013487."},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1613273","article-title":"Primary sclerosing cholangitis","author":"Lazaridis K, LaRusso N","journal-title":"<em>New Engl J Med<\/em>"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.12.002","article-title":"Gut-liver immunity","author":"Trivedi P, Adams D","journal-title":"<em>J Hepatol<\/em>"},{"key":"12","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","unstructured":"12.     Kummen M, Holm K, Anmarkrud J, et al. (2016) The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. <em>Gut<\/em> 66: 611\u2013619."},{"key":"13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","author":"Bajer L, Kverka M, Kostovcik M, et al.","journal-title":"<em>World J Gastroentero<\/em>"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","author":"Sabino J, Vieira-Silva S, Machiels K, et al.","journal-title":"<em>Gut<\/em>"},{"key":"15","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","unstructured":"15.     Tabibian J, O-Hara S, Trussoni C, et al. (2015) Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis. <em>Hepatology<\/em> 63: 185\u2013196."},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of n-ras activation is a characteristic of primary sclerosing choalngitis","author":"Tabibian J, O'Hara S, Splinter P, et al.","journal-title":"<em>Hepatology<\/em>"},{"key":"17","article-title":"Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies","unstructured":"17.     Tabibian J, O'Hara S, Lindor K (2014) Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. <em>Scand J Gastroentero <\/em>49: 901\u2013908."},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13154","article-title":"A comprehensive assessment of environmental exposures among 1000 north american patients with primary sclerosing cholangitis, with and without inflammatory bowel disease","author":"Eaton J, Juran B, Atkinson E, et al.","journal-title":"<em>Aliment Pharm Therap<\/em>"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90224-9","article-title":"Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline","author":"Lichtman S, Keku J, Schwab J, et al.","journal-title":"<em>Gastroenterology<\/em>"},{"key":"20","article-title":"Role of the microbiota and antibiotics in primary sclerosing cholangitis","unstructured":"20.     Tabibian J, Talwalkar J, Lindor K (2013) Role of the microbiota and antibiotics in primary sclerosing cholangitis. <em>Biomed Res Int <\/em>2013: 1\u20137."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis-a pilot study","author":"Tabibian J, Weeding E, Jorgensen R, et al.","journal-title":"<em>Aliment Pharm Therap<\/em>"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1111\/imj.1965.14.4.286","article-title":"Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis","author":"Mistilis S, Skyring A, Goulston S","journal-title":"<em>Australas Ann Med<\/em>"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","author":"F\u00e4rkkil\u00e4 M, Karvonen A, Nurmi H, et al.","journal-title":"<em>Hepatology<\/em>"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","author":"Silveira M, Torok N, Gossard A, et al.","journal-title":"<em>Am J Gastroenterol<\/em>"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(59)90098-4","article-title":"The liver in ulcerative colitis; treatment of pericholangitis with tetracycline","author":"Rankin J, Sydney M, Boden R, et al.","journal-title":"<em>Lancet<\/em>"},{"key":"26","article-title":"Metronidazole in primary cholangitis","unstructured":"26.     Mathew K (1983) Metronidazole in primary cholangitis. <em>J Indian Med<\/em> <em>Assoc<\/em> 80: 31\u201333."},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00740.x","article-title":"Case report: three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine","author":"Kozaiwa K, Tajiri H, Sawada A, et al.","journal-title":"<em>J Gastroen Hepatol<\/em>"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199811000-00015","article-title":"Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease","author":"Cox KL, Cox KM","journal-title":"<em>J Pediatr Gastr Nutr<\/em>"},{"key":"29","article-title":"Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis","unstructured":"29.     Broccoletti T, Ciccimarra E, Spaziano M, et al. (2002) Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis. <em>Ital J Pediatr<\/em> 28: 515\u2013517."},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-005-1758-x","article-title":"Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis","author":"Tada S, Ebinuma H, Saito H, et al.","journal-title":"<em>J Gastroenterol<\/em>"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1177\/039463200702000423","article-title":"Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation","author":"Boner A, Peroni D, Bodini A, et al.","journal-title":"<em>Int J Immunopath Ph<\/em>"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","author":"Davies Y, Cox K, Abdullah B, et al.","journal-title":"<em>J Pediatr Gastr Nutr<\/em>"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200601000-00012","article-title":"The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis","author":"Pohl J, Ring A, Stremmel W, et al.","journal-title":"<em>Eur J Gastroen Hepat<\/em>"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80153-1","article-title":"Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis","author":"Hiramatsu K, Harada K, Tsuneyama K, et al.","journal-title":"<em>J Hepatol<\/em>"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers","author":"Olsson R, Bjornsson E, Backman L, et al.","journal-title":"<em>J Hepatol<\/em>"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80058-5","article-title":"Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis","author":"Sasatomi K, Noguchi K, Sakisaka S","journal-title":"<em>J Hepatol<\/em>"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study","author":"Vleggaar F, Monkelbaan J, Van Erpecum K","journal-title":"<em>Eur J Gastroen Hepat<\/em>"},{"key":"38","article-title":"Fecal microbiota transplantation improves microbiome diversity and liver enzyme profile in primary sclerosing cholangitis","unstructured":"38.     Allegretti J, Kassam Z, Carrellas M, et al. (2017) Fecal microbiota transplantation improves microbiome diversity and liver enzyme profile in primary sclerosing cholangitis. <em>World Congress of Gastroenterology at ACG2017 Meeting Abstracts<\/em>."},{"key":"39","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","unstructured":"39.     David L, Maurice C, Carmody R, et al (2013) Diet rapidly and reproducibly alters the human gut microbiome. <em>Nature<\/em> 505: 559\u2013563."},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.09.024","article-title":"Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis","author":"Andersen I, Tengesdal G, Lie B, et al.","journal-title":"<em>Clin Gastroenterol H<\/em>"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.12.036","article-title":"Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis","author":"Lammert C, Juran B, Schlicht E, et al.","journal-title":"<em>Clin Gastroenterol H<\/em>"},{"key":"42","article-title":"The gut microbiota in primary sclerosing cholangitis and inflammatory bowel disease: correlations with disease and diet","unstructured":"42.     Torres J, Palmela C, Bao X, et al. (2016) The gut microbiota in primary sclerosing cholangitis and inflammatory bowel disease: correlations with disease and diet. <em>Microbiology<\/em> 150: S583\u2013S584."},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","author":"Boonstra K, Beuers U, Ponsioen C","journal-title":"<em>J Hepatol<\/em>"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.12","article-title":"Novel therapeutic targets in primary biliary cirrhosis","author":"Dyson J, Hirschfield G, Adams D, et al.","journal-title":"<em>Nat Rev Gastro Hepat<\/em>"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111864","article-title":"Impact of microbes on the pathogenesis of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)","author":"Mattner J","journal-title":"<em>Int J Mol Sci<\/em>"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","author":"Kaplan M, Gershwin E","journal-title":"<em>New Engl J Med<\/em>"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","author":"Selmi C, Bowlus C, Gershwin E, et al.","journal-title":"<em>Lancet<\/em>"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-2920.2012.02824.x","article-title":"Bile salts induce long polar fimbriae expression favouring crohn's disease-associated adherent-invasive escherichia coli interaction with peyer's patches","author":"Chassaing B, Etienne-Mesmin L, Bonnet R, et al.","journal-title":"<em>Environ Microbiol<\/em>"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","author":"Kakiyama G, Pandak W, Gillevet P, et al.","journal-title":"<em>J Hepatol<\/em>"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","author":"Lv L, Fang D, Shi D, et al.","journal-title":"<em>Environ Microbiol<\/em>"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80058-5","article-title":"Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis","author":"Sasatomi K, Noguchi K, Sakisaka S, et al.","journal-title":"<em>J Hepatol<\/em>"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuw007","article-title":"Lipopolysaccharide modification in gram-negative bacteria during chronic infection","author":"Maldonado R, Sa-Correia I, Valvano M","journal-title":"<em>FEMS Microbiol Rev<\/em>"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2005.05.003","article-title":"Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis","author":"Wang A, Migita K, Ito M, et al.","journal-title":"<em>J Autoimmun<\/em>"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2012.07.001","article-title":"Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis c","author":"Benias P, Gopal K, Bodenheimer H, et al.","journal-title":"<em>Clin Res Hepatol Gas<\/em>"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","author":"Seki E, Brenner D","journal-title":"<em>Hepatology<\/em>"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","author":"Wahlstr\u00f6m A, Sayin S, Marschall H, et al.","journal-title":"<em>Cell Metab<\/em>"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0b013e32836410a4","article-title":"The gut-liver axis","author":"Visschers R, Luyer M, Schaap F, et al.","journal-title":"<em>Curr Opin Clin Nutr<\/em>"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","author":"Lindor K, Gershwin E, Poupon R, et al.","journal-title":"<em>Hepatology<\/em>"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","author":"Beuers U, Boberg K, Chapman R","journal-title":"<em>J Hepatol<\/em>"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M039834","article-title":"Contribution of the 7\u03b2-hydroxysteroid dehydrogenase from ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon","author":"Lee J, Arai H, Nakamura Y, et al.","journal-title":"<em>J Lipid Res<\/em>"},{"key":"61","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","unstructured":"61.     Tang R, Wei Y, Che W, et al. (2017) Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. <em>Gut<\/em> 67: 534\u2013541."},{"key":"62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92034-5","article-title":"Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis","author":"Hopf U, Moller B, Stemerowicz R, et al.","journal-title":"<em>Lancet<\/em>"},{"key":"63","article-title":"Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis","unstructured":"63.     Bogdanos D, Baum H, Grasso A, et al. (2004) Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. <em>J Hepatol<\/em> 40: 31\u201339."},{"key":"64","article-title":"Antimitochondrial antibodies and reactivity to N","unstructured":"64.     Olafsson S, Gudjonsson H, Selmi C, et al. (2004) Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in icelandic patients with primary biliary cirrhosis and their relatives. <em>Am J Gastroenterol<\/em> 99: 2143\u20132146."},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2008.03.009","article-title":"Liver autoimmunity triggered by microbial activation of natural killer T cells","author":"Mattner J, Savage P, Leung P, et al.","journal-title":"<em>Cell Host Microbe<\/em>"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2011.07.013","article-title":"Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside","author":"Smyk D, Bogdanos D, Kriese S, et al.","journal-title":"<em>Clin Res Hepatol Gas<\/em>"},{"key":"67","article-title":"Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry","unstructured":"67.     Rashid T, Ebringer A (2012) Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry. <em>Autoimmune Dis<\/em>: 1\u20139."},{"key":"68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90235-8","article-title":"Are antimitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriaceae","author":"Stemerowicz R, Hopf U, Moller B, et al.","journal-title":"<em>Lancet<\/em>"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0586-z","article-title":"Autoimmune hepatitis: a review","author":"Gossard A, Lindor K","journal-title":"<em>J Gastroenterol<\/em>"},{"key":"70","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of brimary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a norwegian population","author":"Boberg K, Aadland E, Jahnse J, et al.","journal-title":"<em>Scand J Gastroentero<\/em>"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in singapore: a rare syndrome affecting middle-aged women","author":"Lee Y, Teo E, Ng T, et al.","journal-title":"<em>J Gastroen Hepatol<\/em>"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","author":"Hurlburt K, McMahon B, Deubner H, et al.","journal-title":"<em>Am J Gastroenterol<\/em>"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1016\/S0210-5705(03)70452-X","article-title":"Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (spain)","author":"Primo J, Merino C, Fernandez J, et al.","journal-title":"<em>Gastroent Hepat-Barc<\/em>"},{"key":"74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women","author":"Ngu J, Bechly K, Chapman B, et al.","journal-title":"<em>J Gastroen Hepatol<\/em>"},{"key":"75","article-title":"Autoimmune hepatitis in southern Israel: a multicenter study of 15 years","unstructured":"75.     Delgado J, Vodonos A, Malnick S, et al. (2013) Autoimmune hepatitis in southern Israel: a multicenter study of 15 years. <em>J Digest Dis<\/em> 14: 611\u2013618."},{"key":"76","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i42.9257","article-title":"Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis","author":"Czaja A","journal-title":"<em>World J Gastroentero<\/em>"},{"key":"77","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","author":"Czaja A","journal-title":"<em>Hepatology<\/em>"},{"key":"78","article-title":"The overlap syndromes of autoimmune hepatitis","unstructured":"78.     Czaja A (2013) The overlap syndromes of autoimmune hepatitis. <em>Digest Dis Sci<\/em> 58: 326\u2013343."},{"key":"79","article-title":"Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis","unstructured":"79.     Lin R, Zhou L, Zhang J, et al. (2015) Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. <em>Int J Clin Exp Patho<\/em> 8: 5153\u20135160."},{"key":"80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2017.09.013","article-title":"Intestinal microbiome and permeability in patients with autoimmune hepatitis","author":"Cai W, Ran Y, Li Y, et al.","journal-title":"<em>Best Pract Res Cl Ga<\/em>"},{"key":"81","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27998","article-title":"A novel humanized mouse model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","author":"Yuksel M, Wang Y, Tai N, et al.","journal-title":"<em>Hepatology<\/em>"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2003.09.013","article-title":"Pathogenesis of diseases associated with antineutrophil cytoplasm autoantibodies","author":"Reumaux D, Duthilleul P, Roos D","journal-title":"<em>Hum Immunol<\/em>"},{"key":"83","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","author":"Terjung B, Sohne J, Lechtenberg B, et al.","journal-title":"<em>Gut<\/em>"}],"container-title":["AIMS Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/microbiol.2018.2.334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T22:59:39Z","timestamp":1526338779000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/10.3934\/microbiol.2018.2.334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3934\/microbiol.2018.2.334","relation":{},"ISSN":["2471-1888"],"issn-type":[{"value":"2471-1888","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}